What is the recommended workup and treatment for a suspected miscarriage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The initial step in managing a suspected miscarriage involves a thorough clinical history, physical examination, and ultrasound evaluation, as outlined in the Society of Radiologists in Ultrasound consensus conference recommendations 1. When a patient presents with suspected miscarriage, the primary goal is to determine the viability of the pregnancy and the type of miscarriage, if any, to guide appropriate management. Key points to consider in the workup include:

  • Ultrasound criteria for early pregnancy loss (EPL), such as embryonic crown-rump length (CRL) <7 mm and no cardiac activity, or mean sac diameter (MSD) 16-24 mm and no embryo 1.
  • The classification of EPL into categories including concerning for, diagnostic of, in progress, incomplete, and completed, which helps in deciding the management approach.
  • The use of serial quantitative beta-hCG measurements to assess pregnancy viability, with the understanding that levels should approximately double every 48-72 hours in a viable pregnancy. Management strategies depend on the type of miscarriage diagnosed:
  • For a complete miscarriage, typically no further intervention is required.
  • For an incomplete or missed miscarriage, options include expectant management, medical management with misoprostol, or surgical management via vacuum aspiration or dilation and curettage. Medical management with misoprostol (800 mcg vaginally or 600 mcg sublingually) is often preferred due to its effectiveness and avoidance of surgical risks 1. Additional considerations include:
  • Administration of anti-D immunoglobulin (RhoGAM) to Rh-negative women to prevent isoimmunization.
  • Monitoring for potential complications such as excessive bleeding, infection, or incomplete evacuation.
  • Providing emotional support, as miscarriage can have significant psychological impacts.
  • Advising patients to wait at least one menstrual cycle before attempting conception again, primarily for accurate dating of a future pregnancy.

From the Research

Suspected Miscarriage Workup

  • The diagnosis of miscarriage is typically made using transvaginal ultrasound (TVS) assessment 2
  • TVS should be considered the standard test to assess viability of the pregnancy 3
  • Assessment of vaginal bleeding is best made in the context of time taken to saturate a sanitary pad, with changing a pad soaked with blood and clots more than once an hour indicating heavy bleeding that requires immediate referral 3

Risk Factors and Treatment

  • Advancing maternal and paternal age, being underweight or overweight, smoking, and high alcohol consumption are known risk factors for miscarriage 3
  • Expectant management is the first-line approach for miscarriage, encouraged for 7-14 days after diagnosis, with most women miscarrying spontaneously during this time 3
  • Medical management of miscarriage can be offered using misoprostol, while surgical management may be chosen by a woman if she has had a previous adverse or traumatic experience associated with pregnancy 3
  • Anti-D prophylaxis is required for women who are rhesus negative and experiencing symptoms of bleeding if the pregnancy is 12 weeks' gestation 3

Diagnostic Criteria and Accuracy

  • Evidence-based criteria should be employed for the diagnosis of delayed and incomplete miscarriage 2
  • Complete miscarriage should not be diagnosed with TVS alone without serial biochemical confirmation, unless an intrauterine gestation sac has previously been visualized 2
  • The sensitivity, specificity, predictive value, and overall diagnostic accuracy of ultrasound are calculated, with transvaginal ultrasound being nondiagnostic in 17.7% of cases 4
  • The use of three-dimensional ultrasound has not improved the diagnosis of miscarriage 2

Follow-up and Monitoring

  • βhCG monitoring can be useful in the follow-up of medical management of miscarriage, with a percentage change in total βhCG levels (%ΔβhCG) predicting treatment outcomes 5
  • %ΔβhCG calculation over one week can reliably predict treatment outcomes after medical management of missed miscarriage 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosing miscarriage.

Best practice & research. Clinical obstetrics & gynaecology, 2009

Research

Diagnosis and management of miscarriage.

The Practitioner, 2014

Research

Utility of βhCG monitoring in the follow-up of medical management of miscarriage.

The Australian & New Zealand journal of obstetrics & gynaecology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.